You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thalassaemia

Showing 1 - 25 of 106
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Transfusion Dependent Beta-Thalassaemia Trial in Nanning (ET-01)

Recruiting
  • Transfusion Dependent Beta-Thalassaemia
  • ET-01
  • Nanning, Guangxi, China
    PLA 923 Hospital
Mar 2, 2023

Transfusion Dependent Beta-Thalassaemia Trial in Guangzhou, Shenzhen, Tianjin (ET-01)

Active, not recruiting
  • Transfusion Dependent Beta-Thalassaemia
  • ET-01
  • Guangzhou, Guangdong, China
  • +3 more
May 9, 2022

Transfusion Dependent Beta-Thalassaemia Trial in Tianjin (ET-01)

Active, not recruiting
  • Transfusion Dependent Beta-Thalassaemia
  • ET-01
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Dec 9, 2021

Thalassemia Major Trial in Ferrara (Blood component A, Blood component B)

Completed
  • Thalassemia Major
  • Blood component A
  • Blood component B
  • Ferrara, Italy
    Day Hospital Thalassaemia and Haemoglobinopathies (DHTE)
Nov 11, 2021

Beta Thalassaemia Trial in Milan (Safety and Efficacy assessments)

Active, not recruiting
  • Beta Thalassaemia
  • Safety and Efficacy assessments
  • Milan, Italy
    Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Nov 22, 2022

Non-transfusion-dependent Thalassemia, Low Risk Myelodysplastic Syndrome, Very-Low Risk Myelodysplastic Syndrome Trial in

Recruiting
  • Non-transfusion-dependent Thalassemia
  • +2 more
  • Düsseldorf, Germany
  • +19 more
Mar 18, 2022

Beta-Thalassemia Trial in Bulgaria, Israel, United States (VIT-2763 60 mg QD, VIT-2763 60 mg BID, VIT-2763 120 mg BID)

Withdrawn
  • Beta-Thalassemia
  • VIT-2763 60 mg QD
  • +3 more
  • Whittier, California
  • +6 more
Nov 7, 2022

Beta-Thalassemia Trial in Ferrara, Firenze, Pisa (Sirolimus 0.5 mg)

Recruiting
  • Beta-Thalassemia
  • Sirolimus 0.5 mg
  • Ferrara, FE, Italy
  • +3 more
Nov 11, 2021

Pyruvate Kinase Deficiency, Anemia, Hemolytic Trial in Worldwide (AG-348)

Completed
Has Results
  • Pyruvate Kinase Deficiency
  • Anemia, Hemolytic
  • Oakland, California
  • +18 more
Dec 14, 2021

Non-transfusion-dependent Thalassemia, Low Risk Myelodysplastic Syndrome Trial in Bulgaria, United Kingdom (SLN124 is a GalNAc

Withdrawn
  • Non-transfusion-dependent Thalassemia
  • Low Risk Myelodysplastic Syndrome
  • SLN124 is a GalNAc conjugated double stranded fully modified siRNA. Sodium chloride 0.9% w/v is used as Placebo
  • Kyustendil, Bulgaria
  • +4 more
Apr 23, 2020

Sickle Cell Disease, Sickle Cell Trait, Beta-Thalassemia Trial (High performance liquid chromatography, Automated sickling test,

Not yet recruiting
  • Sickle Cell Disease
  • +4 more
  • High performance liquid chromatography
  • +5 more
  • (no location specified)
Aug 17, 2022

Pyruvate Kinase Deficiency, Anemia, Hemolytic Trial in Worldwide (Placebo, AG-348)

Completed
Has Results
  • Pyruvate Kinase Deficiency
  • Anemia, Hemolytic
  • Little Rock, Arkansas
  • +45 more
May 20, 2022

Thalassemia Major, Transfusion-dependent Anemia Trial in Guangzhou (Luspatercept Injectable Product)

Recruiting
  • Thalassemia Major
  • Transfusion-dependent Anemia
  • Luspatercept Injectable Product
  • Guangzhou, Guangdong, China
    The second affiliated hospital of Sun Yat-sen University
Jul 15, 2022

Type 3 Von Willebrand International Registries Inhibitor

Active, not recruiting
Has Results
  • Type 3 Von Willebrand's Disease
  • Von Willebrand Factor
  • Helsinki, Finland
  • +24 more
Mar 21, 2022

Transfusion-dependent Thalassemia Trial in Dhaka (Thalidomide Capsules, Placebo)

Recruiting
  • Transfusion-dependent Thalassemia
  • Thalidomide Capsules
  • Placebo
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
Oct 18, 2023

ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

Recruiting
  • β-thalassemia
  • β-globin restored autologous hematopoietic stem cells
  • Shenzhen, Guangdong, China
    Shenzhen Children's Hospital
Feb 24, 2023

Hemoglobinopathies and Rare Inherited Anemia and Covid 19

Recruiting
  • Haemoglobinopathies
    • Genova, Italy
    • +1 more
    May 4, 2022

    ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

    Recruiting
    • β-thalassemia
    • β-globin restored autologous hematopoietic stem cells
    • Shenzhen, Guangdong, China
      Shenzhen University General Hospital
    May 8, 2023

    Transfusion-dependent ß-thalassemia Patients, Cardiac Iron Overload Trial in Athens, Patras (Deferasirox, Deferoxamine (DFO))

    Terminated
    Has Results
    • Transfusion-dependent β-thalassemia Patients
    • Cardiac Iron Overload
    • Athens, GR, Greece
    • +3 more
    Oct 21, 2019

    Thalassemia, Iron Overload Trial in Nanning (CN128 Tablets)

    Active, not recruiting
    • Thalassemia
    • Iron Overload
    • CN128 Tablets
    • Nanning, Guangxi, China
      The First Affiliated Hospital Of Guangxi Medical University
    Aug 3, 2022

    Thalassemia Trial in Peshawar (Thalidomide and Hydroxyurea)

    Completed
    • Thalassemia
    • Thalidomide and Hydroxyurea
    • Peshawar, Khyber Pakhtukhwa, Pakistan
      Blood Diseases Clinic
    Mar 10, 2022

    Transfusion-dependent Beta-Thalassemia Trial in Tianjin (KL003 cell injection Drug Product)

    Not yet recruiting
    • Transfusion-dependent Beta-Thalassemia
    • KL003 cell injection Drug Product
    • Tianjin, Tianjin, China
      Regenerative Medicine Center
    May 8, 2023

    Atrial Fibrillation in Beta-Thalassemia

    Not yet recruiting
    • Atrial Fibrillation
    • Thalassemia
      • Ferrara, Italy
        Matteo Bertini
      Aug 18, 2022

      Clinical Presentation of Genetic Disorders in Patients Attending

      Not yet recruiting
      • Genetic Disease Clinical Presentation in Patients Attending Genetics Outpatient Clinic of Assiut University Children Hospital
        • (no location specified)
        Jun 2, 2023

        Beta Thalassemia Intermedia Trial in Worldwide (IONIS TMPRSS6-LRx)

        Active, not recruiting
        • Beta Thalassemia Intermedia
        • Camperdown, New South Wales, Australia
        • +18 more
        Sep 23, 2022